Cosmo Pharmaceuticals N.V. 13D/13G Filings for

Cosmo Pharmaceuticals N.V. 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-03-07
5:25 pm
Purchase
2019-10-1713GREDHILL BIOPHARMA LTD
RDHL
Cosmo Pharmaceuticals N.V.69,000
13.200%
69,000increase
(New Position)
Filing